+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Protein Supplement Market by Type, Form, Source, Gender, Age Group and Distribution Channel: Opportunity Analysis and Industry Forecast, 2021-2028

  • PDF Icon

    Report

  • 165 Pages
  • July 2021
  • Region: United States
  • Allied Market Research
  • ID: 5439863
Protein is a critical component of hormones, vital organs, immunity system, and nervous system. It is usually found in meat & animal products such as beef, dairy, fish, & poultry and plant-based products including soy, beans, nuts, & whole grains. Modified high-quality protein sources include different types of protein supplements in the form of powder, shakes, and bars. Protein supplements build, repair and maintain muscles, skin, and hair in the body. They also help reduce weight, lower cholesterol, strengthen immunity, prevent cardiovascular diseases, and several other benefits. These are generally bought from online fitness stores owing to availability of numerous options and convenience of consumers.

The growth of the U.S. protein supplement market is driven by increase in health-related concerns, which has led to a shift of individuals toward fitness centers, gyms, and health clubs. Furthermore, rise in obesity rates and growth in disposable income are some other factors that drive the growth of the market. However, presence of cheaper substitutes, side-effects of protein supplements, and negative publicity & claims are expected to hamper the growth of market during the forecast period. Growth in demand from health-conscious young population and introduction of protein supplements in untapped economies are anticipated to provide lucrative opportunities for the expansion of the market.

The report segments the U.S. protein supplement market based on type, form, source, gender, age group, and distribution channel. By type, the market is divided into casein, whey protein, egg protein, soy protein, and others. On the basis of form, it is classified into powder, RTD liquid, and protein bars. On account of source, the market is segmented into animal and plant sources.

On the basis of gender, the market is bifurcated into male and female. On the basis of age group, the market is classified into millennial, generation X, and baby boomer. Based on distribution channel, it is categorized into supermarkets/hypermarkets, e-commerce, chemist/drugstore, nutrition store, health food store, specialist sports store, and others.

The key market players are: Abbott Laboratories, ABH Pharma Inc., Amway Corporation, Glanbia Corp., GlazoSmithKline, GNC Holdings, Herbalife International of America Inc., Bob's Red Mill, Nutiva Inc., and MusclePharm Corporation. The major strategies adopted by key players to expand their business include expansion in untapped regions and new product launches.

Key benefits for stakeholders

  • This report provides a quantitative analysis of the current trends, estimations, and dynamics of the U.S. protein supplement market from 2019 to 2028 to identify the prevailing market opportunities.
  • Porter’s five forces analysis highlights the potency of the buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network.
  • In-depth analysis of the U.S. protein supplement market segmentation assists in determining the prevailing market opportunities.
  • The report includes an analysis of U.S. protein supplement market, key players, market segments application areas, and growth strategies.

Key market segment


By Type

  • Casein
  • Whey Protein
  • Egg Protein
  • Soy Protein
  • Other

By Form

  • Powder
  • RTD Liquid
  • Protein Bar

By Source

  • Animal
  • Plant

By Gender

  • Male
  • Female

By Age Group

  • Millennial
  • Generation X
  • Baby Boomer

By Distribution Channel

  • Hypermarket/Supermarket
  • E-Commerce
  • Chemist/Drugstore
  • Nutrition Store
  • Health Food Store
  • Specialist Sports Store
  • Others

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segment
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter's five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in awareness among people for health & fitness
3.4.1.2. Alarming rise in obesity rates
3.4.1.3. Increase in disposable income
3.4.1.4. Rise in demand for supplement from the millennial population
3.4.2. Restraints
3.4.2.1. Presence of cheaper substitutes
3.4.2.2. Side-effects and negative publicity & claims
3.4.3. Opportunity
3.4.3.1. Growth in demand from young population
3.5. US protein supplement market: covid-19 Impact analysis

CHAPTER 4: U. S. PROTEIN SUPPLEMENT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Casein
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast
4.3. Whey protein
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast
4.4. Egg protein
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast
4.5. Soy protein
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast

CHAPTER 5: U. S. PROTEIN SUPPLEMENT MARKET, BY FORM
5.1. Overview
5.1.1. Market size and forecast
5.2. Powder
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast
5.3. RTD liquid
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast
5.4. Protein bar
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast

CHAPTER 6: U. S. PROTEIN SUPPLEMENT MARKET, BY SOURCE
6.1. Overview
6.1.1. Market size and forecast
6.2. Animal
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast
6.3. Plant
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast

CHAPTER 7: U. S. PROTEIN SUPPLEMENT MARKET, BY GENDER
7.1. Overview
7.1.1. Market size and forecast
7.2. Male
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast
7.3. Female
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast

CHAPTER 8: U. S. PROTEIN SUPPLEMENT MARKET, BY AGE GROUP
8.1. Overview
8.1.1. Market size and forecast
8.2. Millennial
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast
8.3. Generation X
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast
8.4. Baby boomer
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast

CHAPTER 9: U. S. PROTEIN SUPPLEMENT MARKET, BY DISTRIBUTION CHANNEL
9.1. Overview
9.1.1. Market size and forecast
9.2. Hypermarkets/Supermarkets
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast
9.3. E-Commerce
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast
9.4. Chemist/Drugstore
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast
9.5. Nutrition store
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast
9.6. Health food store
9.6.1. Key market trends, growth factors and opportunities
9.6.2. Market size and forecast
9.7. Specialist sports store
9.7.1. Key market trends, growth factors and opportunities
9.7.2. Market size and forecast
9.8. Others
9.8.1. Key market trends, growth factors and opportunities
9.8.2. Market size and forecast

CHAPTER 10: COMPETITION LANDSCAPE
10.1. Top winning strategies
10.2. Product mapping
10.3. Competitive dashboard
10.4. Competitive heat map
10.5. Key developments
10.5.1. Acquisition
10.5.2. Product Launch
10.5.3. Partnership
10.5.4. Agreement

CHAPTER 11: COMPANY PROFILES
11.1. ABBOTT LABORATORIES (ABBOTT)
11.1.1. Company overview
11.1.2. Key Executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. R&D Expenditure
11.1.7. Business performance
11.1.8. Key strategic moves and developments
11.2. ABH PHARMA INC
11.2.1. Company overview
11.2.2. Key Executives
11.2.3. Company snapshot
11.2.4. Product portfolio
11.3. AMWAY CORPORATION (AMWAY)
11.3.1. Company overview
11.3.2. Key Executives
11.3.3. Company snapshot
11.3.4. Product portfolio
11.4. BOB'S RED MILL
11.4.1. Company overview
11.4.2. Key Executives
11.4.3. Company snapshot
11.4.4. Product portfolio
11.4.5. Key strategic moves and developments
11.5. GENERAL NUTRITION CORPORATION (GNC HOLDINGS, INC.)
11.5.1. Company overview
11.5.2. Key Executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.5.6. R&D Expenditure
11.5.7. Business performance
11.5.8. Key strategic moves and developments
11.6. GLANBIA PLC.
11.6.1. Company overview
11.6.2. Key Executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.6.6. R&D Expenditure
11.6.7. Business performance
11.6.8. Key strategic moves and developments
11.7. GLAXOSMITHKLINE PLC. (GSK)
11.7.1. Company overview
11.7.2. Key Executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. R&D Expenditure
11.7.7. Business performance
11.7.8. Key strategic moves and developments
11.8. HERBALIFE INTERNATIONAL OF AMERICA INC.
11.8.1. Company overview
11.8.2. Key Executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.8.6. Business performance
11.9. MUSCLEPHARM CORPORATION
11.9.1. Company overview
11.9.2. Key Executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. R&D Expenditure
11.9.7. Business performance
11.9.8. Key strategic moves and developments
11.10. NUTIVA INC.
11.10.1. Company overview
11.10.2. Key Executives
11.10.3. Company snapshot
11.10.4. Product portfolio
11.10.5. Key strategic moves and developmentsLIST OF TABLES
TABLE 01. U.S. PROTEIN SUPPLEMENT MARKET REVENUE, BY TYPE, 2019-2028 ($MILLION)
TABLE 02. U.S. PROTEIN SUPPLEMENT MARKET VOLUME, BY TYPE, 2019-2028 (KILOTON)
TABLE 03. U.S. CASEIN PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 04. U.S. CASEIN PROTEIN SUPPLEMENT MARKET VOLUME, 2019-2028 (KILOTON)
TABLE 05. U.S. WHEY PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 06. U.S. WHEY PROTEIN SUPPLEMENT MARKET VOLUME, 2019-2028 (KILOTON)
TABLE 07. U.S. EGG PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 08. U.S. EGG PROTEIN SUPPLEMENT MARKET VOLUME, 2019-2028 (KILOTON)
TABLE 09. U.S. SOY PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 10. U.S. SOY PROTEIN SUPPLEMENT MARKET VOLUME, 2019-2028 (KILOTON)
TABLE 11. U.S. OTHER PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 12. U.S. OTHER PROTEIN SUPPLEMENT MARKET VOLUME, 2019-2028 (KILOTON)
TABLE 13. U.S. PROTEIN SUPPLEMENT MARKET REVENUE, BY FORM, 2019-2028 ($MILLION)
TABLE 14. U.S. POWDER PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 15. U.S. RTD LIQUID PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 16. U.S. PROTEIN BAR MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 17. U.S. PROTEIN SUPPLEMENT MARKET REVENUE, BY SOURCE, 2019-2028 ($MILLION)
TABLE 18. U.S. ANIMAL PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 19. U.S. PLANT PROTEIN SUPPLEMENT MARKET REVENUE, 2019-2028 ($MILLION)
TABLE 20. U.S. PROTEIN SUPPLEMENT MARKET REVENUE, BY GENDER, 2019-2028 ($MILLION)
TABLE 21. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR MALE, 2019-2028 ($MILLION)
TABLE 22. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR FEMALE, 2019-2028 ($MILLION)
TABLE 23. U.S. PROTEIN SUPPLEMENT MARKET REVENUE, BY AGE GROUP, 2019-2028 ($MILLION)
TABLE 24. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR MILLENIAL, 2019-2028 ($MILLION)
TABLE 25. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR GENERATION X, 2019-2028 ($MILLION)
TABLE 26. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR BABY BOOMER, 2019-2028 ($MILLION)
TABLE 27. U.S. PROTEIN SUPPLEMENT MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2019-2028 ($MILLION)
TABLE 28. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR HYPERMARKETS/SUPERMARKETS, 2019-2028 ($MILLION)
TABLE 29. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR E-COMMERCE, 2019-2028 ($MILLION)
TABLE 30. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR CHEMIST/DRUGSTORE, 2019-2028 ($MILLION)
TABLE 31. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR NUTRITION STORE, 2019-2028 ($MILLION)
TABLE 32. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR HEALTH FOOD STORE, 2019-2028 ($MILLION)
TABLE 33. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR SPECIALIST SPORTS STORE, 2019-2028 ($MILLION)
TABLE 34. U.S. PROTEIN SUPPLEMENT MARKET REVENUE FOR OTHERS, 2019-2028 ($MILLION)
TABLE 35. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 36. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 37. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 38. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 39. ABBOTT LABORATORIES: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 40. ABBOTT LABORATORIES: NET SALES, 2018-2020 ($MILLION)
TABLE 41. ABH PHARMA INC: KEY EXECUTIVES
TABLE 42. ABH PHARMA INC: COMPANY SNAPSHOT
TABLE 43. ABH PHARMA INC: PRODUCT PORTFOLIO
TABLE 44. AMWAY: KEY EXECUTIVES
TABLE 45. AMWAY: COMPANY SNAPSHOT
TABLE 46. AMWAY: PRODUCT PORTFOLIO
TABLE 47. BOB’S RED MILL: KEY EXECUTIVES
TABLE 48. BOB’S RED MILL: COMPANY SNAPSHOT
TABLE 49. BOB’S RED MILL: PRODUCT PORTFOLIO
TABLE 50. GNC HOLDINGS, INC.: KEY EXECUTIVES
TABLE 51. GNC HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 52. GNC HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 53. GNC HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 54. GNC HOLDINGS, INC.: R&D EXPENDITURE, 2017-2019 ($MILLION)
TABLE 55. GNC HOLDINGS, INC.: NET SALES, 2017-2019 ($MILLION)
TABLE 56. GLANBIA PLC: KEY EXECUTIVES
TABLE 57. GLANBIA PLC: COMPANY SNAPSHOT
TABLE 58. GLANBIA PLC: OPERATING SEGMENTS
TABLE 59. GLANBIA PLC: PRODUCT PORTFOLIO
TABLE 60. GLANBIA PLC: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 61. GLANBIA PLC: NET SALES, 2018-2020 ($MILLION)
TABLE 62. GSK: KEY EXECUTIVES
TABLE 63. GSK: COMPANY SNAPSHOT
TABLE 64. GSK: OPERATING SEGMENTS
TABLE 65. GSK: PRODUCT PORTFOLIO
TABLE 66. GSK: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 67. GSK: NET SALES, 2018-2020 ($MILLION)
TABLE 68. HERBALIFE INTERNATIONAL OF AMERICA, INC.: KEY EXECUTIVES
TABLE 69. HERBALIFE INTERNATIONAL OF AMERICA, INC.: COMPANY SNAPSHOT
TABLE 70. HERBALIFE INTERNATIONAL OF AMERICA, INC.: OPERATING SEGMENTS
TABLE 71. HERBALIFE INTERNATIONAL OF AMERICA, INC: PRODUCT PORTFOLIO
TABLE 72. HERBALIFE INTERNATIONAL OF AMERICA, INC: NET SALES, 2018-2020 ($MILLION)
TABLE 73. MUSCLEPHARM CORPORATION: KEY EXECUTIVES
TABLE 74. MUSCLEPHARM CORPORATION: COMPANY SNAPSHOT
TABLE 75. MUSCLEPHARM CORPORATION: OPERATING SEGMENTS
TABLE 76. MUSCLEPHARM CORPORATION: PRODUCT PORTFOLIO
TABLE 77. MUSCLEPHARM CORPORATION: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 78. MUSCLEPHARM CORPORATION: NET SALES, 2018-2020 ($MILLION)
TABLE 79. NUTIVA INC: KEY EXECUTIVES
TABLE 80. NUTIVA INC: COMPANY SNAPSHOT
TABLE 81. NUTIVA INC: PRODUCT PORTFOLIOLIST OF FIGURES
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. EXECUTIVE SUMMARY
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. MODERATE TO HIGH THREAT OF SUBSTITUTES
FIGURE 07. HIGH INTENSITY OF RIVALRY
FIGURE 08. LOW TO MODERATE BARGAINING POWER OF BUYERS
FIGURE 09. U.S. PROTEIN SUPPLEMENT MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10. U.S. PROTEIN SUPPLEMENT MARKET, BY TYPE, 2019 (%)
FIGURE 11. U.S. PROTEIN SUPPLEMENT MARKET, BY FORM, 2019 (%)
FIGURE 12. U.S. PROTEIN SUPPLEMENT MARKET, BY SOURCE, 2019 (%)
FIGURE 13. U.S. PROTEIN SUPPLEMENT MARKET, BY GENDER, 2019 (%)
FIGURE 14. U.S. PROTEIN SUPPLEMENT MARKET, BY AGE GROUP, 2019 (%)
FIGURE 15. U.S. PROTEIN SUPPLEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019 (%)
FIGURE 16. TOP WINNING STRATEGIES, BY YEAR, 2018-2021*
FIGURE 17. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021* (%)
FIGURE 18. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021*
FIGURE 19. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 20. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 21. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 22. ABBOTT LABORATORIES: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 23. ABBOTT LABORATORIES: NET SALES, 2018-2020 ($MILLION)
FIGURE 24. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26. GNC HOLDINGS, INC.: R&D EXPENDITURE, 2017-2019 ($MILLION)
FIGURE 27. GNC HOLDINGS, INC.: NET SALES, 2017-2019 ($MILLION)
FIGURE 28. GNC HOLDINGS, INC.: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 29. GNC HOLDINGS, INC.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 30. GLANBIA PLC: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 31. GLANBIA PLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 32. GLANBIA PLC: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 33. GLANBIA PLC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34. GSK: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 35. GSK: NET SALES, 2018-2020 ($MILLION)
FIGURE 36. GSK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37. GSK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38. HERBALIFE INTERNATIONAL OF AMERICA, INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 39. HERBALIFE INTERNATIONAL OF AMERICA, INC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40. HERBALIFE INTERNATIONAL OF AMERICA, INC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41. MUSCLEPHARM CORPORATION: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 42. MUSCLEPHARM CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 43. MUSCLEPHARM CORPORATION: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned

  • Abbott Laboratories
  • ABH Pharma Inc.
  • Amway Corporation
  • Glanbia Corp.
  • GlazoSmithKline
  • GNC Holdings
  • Herbalife International of America Inc.
  • Bob's Red Mill
  • Nutiva Inc.
  • MusclePharm Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...